Recent genomic screens for HNSCC and oral precancer have identified multiple druggable targets that play a role in cell cycle regulation in these (pre)malignant cells such as PLK1, WEE1, and CHEK1 [38,39,40]. The gene discussed is CHEK1; the disease is head and neck squamous cell carcinoma.